ACQUIRED ATTR AMYLOIDOSIS

ACQUIRED ATTR AMYLOIDOSIS was reported 41 times

ACQUIRED ATTR AMYLOIDOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antisense Oligonucleotide [EPC] 2 0.0002
1 Dipeptidyl Peptidase 4 Inhibitor [EPC] 3 0.0001
2 Factor Xa Inhibitor [EPC] 16 0.0001
3 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
4 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1 0.0000
5 Provitamin D2 Compound [EPC] 1 0.0000
6 Aldosterone Antagonist [EPC] 5 0.0000
7 Cardiac Glycoside [EPC] 2 0.0000
8 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 3 0.0000
9 Muscle Relaxant [EPC] 1 0.0000
10 alpha-Adrenergic Blocker [EPC] 3 0.0000
11 5-alpha Reductase Inhibitor [EPC] 2 0.0000
12 P2Y12 Platelet Inhibitor [EPC] 2 0.0000
13 beta-Adrenergic Blocker [EPC] 5 0.0000
14 Glycopeptide Antibacterial [EPC] 1 0.0000
15 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
16 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
17 Prostaglandin Analog [EPC] 1 0.0000
18 Antiarrhythmic [EPC] 1 0.0000
19 Aminosalicylate [EPC] 1 0.0000
20 Angiotensin 2 Receptor Blocker [EPC] 3 0.0000
21 Loop Diuretic [EPC] 4 0.0000
22 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
23 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
24 Azole Antifungal [EPC] 1 0.0000
25 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
26 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
27 Corticosteroid [EPC] 6 0.0000
28 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
29 Alkylating Drug [EPC] 1 0.0000
30 Platelet Aggregation Inhibitor [EPC] 2 0.0000
31 Proton Pump Inhibitor [EPC] 2 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
34 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
35 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
36 Vitamin C [EPC] 1 0.0000